Patricia S Caldera

Title: **Patricia S. Caldera: Innovating in Retroviral Research**

Introduction

Patricia S. Caldera is an accomplished inventor based in San Francisco, CA, known for her significant contributions to retroviral research. She has developed innovative methods and compounds that aid in the detection, labeling, and inhibition of retroviral proteases, which are crucial in the fight against HIV.

Latest Patents

Patricia holds one patent titled "Protease-binding compounds and methods of use." This patent showcases non-peptide, protease-binding compounds that have demonstrated utility in targeting retroviral proteases, specifically those associated with HIV-1 and HIV-2. The innovative aryl piperidinyl derivatives and structurally related compounds presented in her work are pivotal in enhancing our understanding and treatment of these viruses.

Career Highlights

Caldera works at the University of California, where she has dedicated her career to advancing scientific research in the field of retrovirology. Her innovative research has paved the way for further developments that could impact therapeutic strategies against HIV. The breadth of her work is a testament to her expertise and commitment to improving health outcomes.

Collaborations

Throughout her career, Patricia has collaborated with esteemed colleagues, including Paul R. Ortiz de Montellano and Irwin D. Kuntz. These collaborations reflect her ability to work within interdisciplinary teams, enhancing the depth and impact of her research endeavors.

Conclusion

Patricia S. Caldera exemplifies the essence of an innovative inventor in the pharmaceutical landscape. Her patent and research contributions are critical in the ongoing battle against retroviruses, and her work will undoubtedly inspire future advancements in the field.